About Index Trending news
Lists
Pricing
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

Sorrento Therapeutics is focused on the development of proprietary drugtherapeutics for addressing unmet medical needs.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Post-IPO equity
$150,000,000
Employees

Unknown size

Locations
HQ
$150,000,000 Post-IPO equity
http://www.avcj.com

Ally Bridge leads $150m round for US cancer treatment firm | AVCJ